Almac Group announces $5.2m expansion

By Melissa Fassbender contact

- Last updated on GMT

Almac first established its presence in the US in 1996 with clinical trial operations in Audubon, Pennsylvania. (Image: iStock/tongdang5)
Almac first established its presence in the US in 1996 with clinical trial operations in Audubon, Pennsylvania. (Image: iStock/tongdang5)

Related tags: Almac group, United states

In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.

Almac currently employs more than 1,600 individuals across six facilities in the US, and expects to create nearly 80 new jobs as part of the expansion.

Update: Almac: investment to ensure space, staff, larger US footprint

The investment will support expansion of the company’s Clinical Services facility as well as the development of its Diagnostics and Clinical Technologies operations. 

As Outsourcing-Pharma.com previously reported​, Almac Group’s Diagnostics Business Unit opened a companion diagnostic development facility earlier this year, giving the company a US base to support further growth.

The facility supports the company’s companion diagnostic (CDx) development partnerships and the downstream delivery of assays for patient testing.

Over the past few years, the company also announced expansions in Asia​ and acquisitions in the UK​ and Ireland​ as well as a new serialization solution​ in April of this year.

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars